Climb Bio to Present at Upcoming Investor Conferences

Investors can watch Climb Bio’s conference presentations live via webcast and access 30-day replays through the Investors & Media section of its website.

Rhea-AI Summary

Climb Bio (CLYM)/b) will participate in two upcoming investor healthcare conferences in September 2026 via fireside chats.Management will appear at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9 from 4:30–5:05 p.m. ET, and at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16 from 8:30–9:05 a.m. ET. Live webcasts and 30-day replays will be available through the Investors & Media section of Climb Bio’s website.

News Market Reaction – CLYM

+1.48% 4.0x vol

2 alerts

+1.48% Session close to close

$863.84M Market Cap

4.0x Rel. Volume

In the Sep 2 session, CLYM gained 1.48%, reflecting a mild positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. Trading volume was very high at 4.0x the daily average, suggesting strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WELLESLEY HILLS, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed below.

Wells Fargo 21st Annual Healthcare Conference
Format: Fireside Chat
Date: Wednesday, September 9
Time: 4:30 – 5:05 p.m. ET

Morgan Stanley 24th Annual Global Healthcare Conference
Format: Fireside Chat
Date: Wednesday, September 16
Time: 8:30 – 9:05 AM a.m. ET

The live webcasts will be accessible via the “Investors & Media” section of the Climb Bio website. Webcast replays will be available on the Climb Bio website beginning approximately two hours after each webcast event and will be archived for at least 30 days.

About Climb Bio, Inc.
Climb Bio, Inc. is a clinical-stage biotechnology company with a mission to deliver high impact, disease-modifying medicines for individuals living with immune-mediated diseases, including those affecting kidney health. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody being developed for IgA nephropathy. For more information, please visit climbbio.com. 

Investors and Media
Carlo Tanzi, Ph.D.
Kendall Investor Relations
ctanzi@kendallir.com

FAQ

When will Climb Bio (CLYM) present at the Wells Fargo 21st Annual Healthcare Conference?

Climb Bio is scheduled for a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, from 4:30–5:05 p.m. ET.

What is the schedule for Climb Bio (CLYM) at the Morgan Stanley 24th Annual Global Healthcare Conference?

Climb Bio will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, from 8:30–9:05 a.m. ET.

How can investors access the Climb Bio (CLYM) conference webcasts?

Live webcasts of both Climb Bio fireside chats will be accessible via the “Investors & Media” section of the Climb Bio website, with replays available there after the events.

How long will Climb Bio (CLYM) conference webcasts be available for replay?

Webcast replays for Climb Bio’s conference appearances will be available on the company’s website beginning approximately two hours after each webcast and will be archived for at least 30 days.